Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Clinical experience with aminoglycosides in dialysis-dependent patients: risk factors for mortality and reassessment of current dosing practices.

Heintz BH, Thompson GR 3rd, Dager WE.

Ann Pharmacother. 2011 Nov;45(11):1338-45. doi: 10.1345/aph.1Q403. Epub 2011 Oct 18.

PMID:
22010003
[PubMed - indexed for MEDLINE]
2.

Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.

Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.

Antimicrob Agents Chemother. 2005 Feb;49(2):760-6.

PMID:
15673761
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.

Graham AC, Mercier RC, Achusim LE, Pai MP.

Ann Pharmacother. 2004 Jun;38(6):936-41. Epub 2004 Apr 14.

PMID:
15084688
[PubMed - indexed for MEDLINE]
4.

Risk factors for acute renal insufficiency in patients with suspected or documented bacterial pneumonia.

Welage LS, Walawander CA, Timm EG, Grasela TH.

Ann Pharmacother. 1994 Apr;28(4):515-22.

PMID:
8038478
[PubMed - indexed for MEDLINE]
5.

Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.

Leibovici L, Paul M, Poznanski O, Drucker M, Samra Z, Konigsberger H, Pitlik SD.

Antimicrob Agents Chemother. 1997 May;41(5):1127-33. Erratum in: Antimicrob Agents Chemother 1997 Nov;41(11):2595.

PMID:
9145881
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.

Ghannam DE, Rodriguez GH, Raad II, Safdar A.

Eur J Clin Microbiol Infect Dis. 2009 Mar;28(3):253-9. doi: 10.1007/s10096-008-0620-5. Epub 2008 Aug 28.

PMID:
18752007
[PubMed - indexed for MEDLINE]
8.

Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia.

Mohr AM, Sifri ZC, Horng HS, Sadek R, Savetamal A, Hauser CJ, Livingston DH.

Surg Infect (Larchmt). 2007 Jun;8(3):349-57.

PMID:
17635058
[PubMed - indexed for MEDLINE]
9.

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.

Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH.

Chest. 2000 Jul;118(1):146-55.

PMID:
10893372
[PubMed - indexed for MEDLINE]
10.

Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate?

O'Shea S, Duffull S, Johnson DW.

Semin Dial. 2009 May-Jun;22(3):225-30. doi: 10.1111/j.1525-139X.2008.00554.x. Epub 2009 Apr 5.

PMID:
19386073
[PubMed - indexed for MEDLINE]
11.

Pharmacological considerations for the proper clinical use of aminoglycosides.

Pagkalis S, Mantadakis E, Mavros MN, Ammari C, Falagas ME.

Drugs. 2011 Dec 3;71(17):2277-94. doi: 10.2165/11597020-000000000-00000. Review.

PMID:
22085385
[PubMed - indexed for MEDLINE]
12.

Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients.

Tamma PD, Turnbull AE, Harris AD, Milstone AM, Hsu AJ, Cosgrove SE.

JAMA Pediatr. 2013 Oct;167(10):903-10. doi: 10.1001/jamapediatrics.2013.196.

PMID:
23921724
[PubMed - indexed for MEDLINE]
13.
14.

Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.

Pastewski AA, Caruso P, Parris AR, Dizon R, Kopec R, Sharma S, Mayer S, Ghitan M, Chapnick EK.

Ann Pharmacother. 2008 Sep;42(9):1177-87. doi: 10.1345/aph.1K346. Epub 2008 Jul 29.

PMID:
18664609
[PubMed - indexed for MEDLINE]
15.

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.

Pintado V, San Miguel LG, Grill F, Mejía B, Cobo J, Fortún J, Martín-Dávila P, Moreno S.

J Infect. 2008 Mar;56(3):185-90. doi: 10.1016/j.jinf.2008.01.003. Epub 2008 Feb 15.

PMID:
18280570
[PubMed - indexed for MEDLINE]
16.

Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.

Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I.

Infect Control Hosp Epidemiol. 2007 Sep;28(9):1054-9. Epub 2007 Jul 12.

PMID:
17932826
[PubMed - indexed for MEDLINE]
17.

Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.

Rybak MJ, Abate BJ, Kang SL, Ruffing MJ, Lerner SA, Drusano GL.

Antimicrob Agents Chemother. 1999 Jul;43(7):1549-55.

PMID:
10390201
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Should aminoglycoside antibiotics be abandoned?

English WP, Williams MD.

Am J Surg. 2000 Dec;180(6):512-5; discussion 515-6.

PMID:
11182409
[PubMed - indexed for MEDLINE]
19.

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

Bartal C, Danon A, Schlaeffer F, Reisenberg K, Alkan M, Smoliakov R, Sidi A, Almog Y.

Am J Med. 2003 Feb 15;114(3):194-8.

PMID:
12637133
[PubMed - indexed for MEDLINE]
20.

Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.

Dager WE, King JH.

Ann Pharmacother. 2006 Jan;40(1):9-14. Epub 2005 Dec 6.

PMID:
16332944
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk